Physician

Marc Edward Agronin, M.D.

According to 2025 Medicare claims, Marc Agronin, M.D. (NPI: 1831205434) practices general psychiatry in the Miami-Miami Beach-Kendall, FL market, with the plurality of this provider's patient population coming from Miami-Dade, FL. This provider's primary affiliated billing organization is MIAMI JEWISH HEALTH SYSTEMS, INC. (NPI: 1851440218; TIN: 590624414) and primary practice location at 33137-2706.

Agronin's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 125 traditional Medicare patients, billed 397 HCPCS/CPT codes, and received $27,765 in Medicare payments. The top billing code was 90792 (Psychiatric diagnostic evaluation with medical services). Part D data shows 958 prescription claims across 113 beneficiaries totaling $46,752 in drug costs, led by Namzaric (Memantine Hcl/Donepezil Hcl). Open Payments data shows 24 records totaling $168,666. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved from a higher plateau to a lower plateau, from $126,434 to $46,752. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$21K$42K2015 Medicare payment: $21,200 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $22,204 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $22,431 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $20,596 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $25,524 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $41,694 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $32,490 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $30,250 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $30,369 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $27,765 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015149338$21,200
2016122355$22,204
2017131355$22,431
2018119371$20,596
2019144412$25,524
2020146690$41,694
2021154424$32,490
2022132397$30,250
2023127427$30,369
2024125397$27,765

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$65K$129K2015 Drug cost: $126,434 (USD; Tot_Drug_Cst)2016 Drug cost: $129,243 (USD; Tot_Drug_Cst)2017 Drug cost: $127,095 (USD; Tot_Drug_Cst)2018 Drug cost: $84,869 (USD; Tot_Drug_Cst)2019 Drug cost: $70,678 (USD; Tot_Drug_Cst)2020 Drug cost: $62,648 (USD; Tot_Drug_Cst)2021 Drug cost: $66,194 (USD; Tot_Drug_Cst)2022 Drug cost: $105,998 (USD; Tot_Drug_Cst)2023 Drug cost: $79,132 (USD; Tot_Drug_Cst)2024 Drug cost: $46,752 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20151661,510$126,434
20161361,382$129,243
20171261,264$127,095
20181071,180$84,869
20191141,139$70,678
20201251,033$62,648
2021122922$66,194
2022109890$105,998
2023113876$79,132
2024113958$46,752

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
90792Psychiatric diagnostic evaluation with medical services4343$133
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more59125$79
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more70178$51

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
NamzaricMemantine Hcl/Donepezil Hcl11330$6,311
Duloxetine HclDuloxetine Hcl381,980$3,043
Memantine HclMemantine Hcl824,030$2,718
Fluvoxamine Maleate ErFluvoxamine Maleate12360$2,360
MirtazapineMirtazapine894,608$2,328

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.4$2,368Otsuka Pharmaceutical Development & Commercialization, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.20$166,298Janssen Research & Development, LLC
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Marc Edward Agronin, M.D.?

Tedicare shows public-source Medicare data for Marc Edward Agronin, M.D. (NPI 1831205434), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Marc Edward Agronin, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Marc Edward Agronin, M.D.?

Marc Edward Agronin, M.D. is linked to MIAMI JEWISH HEALTH SYSTEMS, INC. (billing NPI 1851440218) in the available physician profile data.

Does Marc Edward Agronin, M.D. have Open Payments data?

Marc Edward Agronin, M.D. has 24 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.